# A Study To Compare The Amount Of CP-690,550 That Is Absorbed Into The Blood Of Healthy Subjects Following Oral Administration Of Two Different Strength Tablets Of CP-690,550

> **NCT01277991** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 30 (estimated)

## Conditions studied

- Arthritis, Rheumatoid

## Interventions

- **DRUG:** Treatment A
- **DRUG:** Treatment B
- **DRUG:** Treatment B
- **DRUG:** Treatment A

## Key facts

- **NCT ID:** NCT01277991
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2011-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01277991

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01277991, "A Study To Compare The Amount Of CP-690,550 That Is Absorbed Into The Blood Of Healthy Subjects Following Oral Administration Of Two Different Strength Tablets Of CP-690,550". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01277991. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*